Anti-neutrophil cytoplasmic antibodies in primary small vessel vasculitides

Scandinavian Journal of Rheumatology

Volumn 25, Issue 2, 1996, Pages 65-69

  Wiik, A S ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

ANCA; Antineutrophil cytoplasmic antibodies; Autoantibodies; Vasculitis

Indexed keywords

GRANULOCYTE ANTIBODY;

HUMAN; MONITORING; PRIORITY JOURNAL; REVIEW; VASCULITIS;

EID: 0029944689     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609069209     Document Type: Review

References (35)

1. Davies D, Moran ME, Niall JF, Ryan GB. Segmental glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology. Br J Med 1982: 285; 606.
2. Hall JB, Wadham B, Wood CD, Ashton V, Adam WR. Vasculitis and glomerulonephritis: A subgroup with anti-neutrophil cytoplasmic antibody. Aust NZ J Med 1984: 14; 277-8.
3. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: A review. Am J Kidney Dis 1990: 15; 517-29.
4. Kallenberg CGM, Cohen Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AEGK, Weening JJ. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today 1991: 12; 61-4.
5. Wegener F. Über eine eigenartige rhinogene granulomatose mit besonderer beteiligung des arteriensystems und der nieren. Beitr Pathol 1939: 102; 36-68.
6. Rasmussen N, Wiik A. Autoimmunity in Wegener's granulomatosis. In: Veldman JE, McCabe JE, Huizing EH, Mygind N, eds. Immunology, Autoimmunity and Transplantation in Otolaryngology: Proceedings of the First International Academic Conference in Immunology and Immunopathology as applied to Otology and Rhinology. Utrecht; Kugler Publications, 1985: 231-6.
7. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985: i; 425-9.
8. Nölle B, Specks U, Lüdemann J, Rohrbach MS, Deremee RA, Gross WL. Anticytoplasmic antibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989: 111; 28-40.
9. Savage COS, Winearls CG, Jones S, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987: i; 1389-93.
10. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993: 91; 1-12.
11. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994: 37; 187-92.
12. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 Criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990: 33; 1094-100.
13. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 Criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990: 33; 1101-7.
14. Savage COS, Winearls CG, Evand DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985: 56; 467-83.
15. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989: 97 Suppl (6); 12-3.
16. Wiik A, van der Woude FJ. The new ACPA/ANCA nomenclature. Neth J Med 1990: 36; 107-8.
17. Wiik A, Rasmussen N, Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. In: van Venrooij W7, Maini RN, eds. Manual of Biological Markers of Disease. The Netherlands.; Kluwer Academic Publishers, 1993: 1-14.
18. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990: 87; 4115-9.
19. Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992: 141; 335-42.
20. Wiik A. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis. Clin Exp Rheumatol 1993: 11; 191-201.
21. van der Woude FJ, Daha MR, van Es LA. The current status of neutrophil cytoplasmic antibodies. Clin Exp Immunol 1989: 78; 143-9.
22. Esnault VLM, Solimani B, Keogan MT, Brownlee AA, Jayne DRW, Lockwood CM. Association of IgM with IgG ANCA in patients presenting with pulmonary hemorrhage. Kidney Int 1992: 41; 1304-10.
23. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989: 149; 2461-5.
24. Jayne DRW, Gaskin G, Pusey CD, Lockwood CM. ANCA and predicting relapse in systemic vasculitis. Q J Med 1995: 88; 127-33.
25. Cohen Tervaert JW, Mulder AHL, Kallenberg CGM, Stegeman CA. Measurement of IgG3 levels of anti-proteinase antibodies is useful in monitoring disease activity in Wegener's granulomatosis. J Am Soc Nephrol 1994: 5; 828. (Abstract)
26. Jayne DRW, Lockwood CM. Pooled immunoglobulin in the management of systemic vasculitis. Proceedings of the Fourth International Workshop on ANCA, Lübeck 1992: (Abstract)
27. Rossi F, Jayne DRW, Lockwood CM, Kazatchkine MD. Anti-idiotypes against antineutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 1991: 83; 298-303.
28. Nässberger L, Sjöholm AG, Jonsson H, Sturfelt G, Åkesson A. Autoantibodies against neutrophil cytoplasmic compounds in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 1990: 81; 380-3.
29. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994: 46; 1-15.
30. Zhao MH, Jones SJ, Lockwood CM. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995: 99; 49-56.
31. Falk RF, Becker M, Terrell R, Jennette JC. Antigen specificity of p-ANCA and of c-ANCA. Am J Kidney Dis 1915: 18; 197. (Abstract)
32. Hagen EC, Andrassy K, Csernok E, Daha MR, Gaskin G, Gross W, et al. The value of indirect immuno-fluorescence and solid phase techniques for ANCA detection. A report on the first phase of an International cooperative study on the standardization of ANCA assays. J Immunol Methods 1993: 159; 1-16.
33. Rasmussen N, Wiik A, Høier-Madsen M, Pedersen K, Baslund B, Wieslander J. c-ANCA in Denmark, 1990. A complete consecutive series. Proceedings of the Fourth International Workshop on ANCA, Lübeck 1992: (Abstract)
34. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s - Is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond 1990: 24; 284-8.
35. Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 1994: 120; 12-17.